MedTrace Logo

Cerebrovascular Autoregulation in Sepsis, Influence of Renal Replacement Therapy

NCT01926301 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2020-06-11

No results posted yet for this study

Summary

The cerebrovascular autoregulation is impaired in patients with severe sepsis and septic shock. A continuous veno-venous hemodialysis may improve impaired cerebrovascular autoregulation.

Hypothesis: continuous hemodialysis recovers impaired cerebrovascular autoregulation in patients with acute severe sepsis and septic shock.

Conditions

  • Severe Sepsis
  • Septic Shock

Interventions

PROCEDURE

continuous veno-venous hemodialysis

Sponsors & Collaborators

  • Johannes Gutenberg University Mainz

    lead OTHER

Principal Investigators

  • Patrick Schramm, MD · Johannes Gutenberg University Mainz

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01926301 on ClinicalTrials.gov